Global mRNA Vaccine Core Enzyme Supply, Demand and Key Producers, 2024-2030

Global mRNA Vaccine Core Enzyme Supply, Demand and Key Producers, 2024-2030

Page: 125

Published Date: 12 Mar 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.

The global mRNA Vaccine Core Enzyme market size is expected to reach $ 1782 million by 2030, rising at a market growth of -2.4% CAGR during the forecast period (2024-2030).

The core manufacturers of mRNA Vaccine Core Enzyme mainly include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, etc. The top four companies in the industry account for about 49% of the market. North America is the largest market, accounting for about 38% of the global market share. In terms of product type, Capping Enzyme have the largest market share of about 25%. From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.

This report studies the global mRNA Vaccine Core Enzyme production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for mRNA Vaccine Core Enzyme and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Vaccine Core Enzyme that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global mRNA Vaccine Core Enzyme total production and demand, 2019-2030, (K Units)
Global mRNA Vaccine Core Enzyme total production value, 2019-2030, (USD Million)
Global mRNA Vaccine Core Enzyme production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global mRNA Vaccine Core Enzyme consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: mRNA Vaccine Core Enzyme domestic production, consumption, key domestic manufacturers and share
Global mRNA Vaccine Core Enzyme production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global mRNA Vaccine Core Enzyme production by Enzyme Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global mRNA Vaccine Core Enzyme production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global mRNA Vaccine Core Enzyme market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, Takara Bio Inc., Novoprotein, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Vaccine Core Enzyme market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Enzyme Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global mRNA Vaccine Core Enzyme Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global mRNA Vaccine Core Enzyme Market, Segmentation by Enzyme Type:
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others

Global mRNA Vaccine Core Enzyme Market, Segmentation by Application:
Biopharmaceutical Companies
Academic and Research Institutions

Companies Profiled:
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology

Key Questions Answered:
1. How big is the global mRNA Vaccine Core Enzyme market?
2. What is the demand of the global mRNA Vaccine Core Enzyme market?
3. What is the year over year growth of the global mRNA Vaccine Core Enzyme market?
4. What is the production and production value of the global mRNA Vaccine Core Enzyme market?
5. Who are the key producers in the global mRNA Vaccine Core Enzyme market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 mRNA Vaccine Core Enzyme Introduction
1.2 World mRNA Vaccine Core Enzyme Supply & Forecast
1.2.1 World mRNA Vaccine Core Enzyme Production Value (2019 & 2023 & 2030)
1.2.2 World mRNA Vaccine Core Enzyme Production (2019-2030)
1.2.3 World mRNA Vaccine Core Enzyme Pricing Trends (2019-2030)
1.3 World mRNA Vaccine Core Enzyme Production by Region (Based on Production Site)
1.3.1 World mRNA Vaccine Core Enzyme Production Value by Region (2019-2030)
1.3.2 World mRNA Vaccine Core Enzyme Production by Region (2019-2030)
1.3.3 World mRNA Vaccine Core Enzyme Average Price by Region (2019-2030)
1.3.4 North America mRNA Vaccine Core Enzyme Production (2019-2030)
1.3.5 Europe mRNA Vaccine Core Enzyme Production (2019-2030)
1.3.6 China mRNA Vaccine Core Enzyme Production (2019-2030)
1.3.7 Latin America mRNA Vaccine Core Enzyme Production (2019-2030)
1.3.8 Middle East & Africa mRNA Vaccine Core Enzyme Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 mRNA Vaccine Core Enzyme Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 mRNA Vaccine Core Enzyme Major Market Trends

2 Demand Summary
2.1 World mRNA Vaccine Core Enzyme Demand (2019-2030)
2.2 World mRNA Vaccine Core Enzyme Consumption by Region
2.2.1 World mRNA Vaccine Core Enzyme Consumption by Region (2019-2024)
2.2.2 World mRNA Vaccine Core Enzyme Consumption Forecast by Region (2025-2030)
2.3 United States mRNA Vaccine Core Enzyme Consumption (2019-2030)
2.4 China mRNA Vaccine Core Enzyme Consumption (2019-2030)
2.5 Europe mRNA Vaccine Core Enzyme Consumption (2019-2030)
2.6 Japan mRNA Vaccine Core Enzyme Consumption (2019-2030)
2.7 South Korea mRNA Vaccine Core Enzyme Consumption (2019-2030)
2.8 ASEAN mRNA Vaccine Core Enzyme Consumption (2019-2030)
2.9 India mRNA Vaccine Core Enzyme Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
3.1 World mRNA Vaccine Core Enzyme Production Value by Manufacturer (2019-2024)
3.2 World mRNA Vaccine Core Enzyme Production by Manufacturer (2019-2024)
3.3 World mRNA Vaccine Core Enzyme Average Price by Manufacturer (2019-2024)
3.4 mRNA Vaccine Core Enzyme Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global mRNA Vaccine Core Enzyme Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for mRNA Vaccine Core Enzyme in 2023
3.5.3 Global Concentration Ratios (CR8) for mRNA Vaccine Core Enzyme in 2023
3.6 mRNA Vaccine Core Enzyme Market: Overall Company Footprint Analysis
3.6.1 mRNA Vaccine Core Enzyme Market: Region Footprint
3.6.2 mRNA Vaccine Core Enzyme Market: Company Product Type Footprint
3.6.3 mRNA Vaccine Core Enzyme Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: mRNA Vaccine Core Enzyme Production Value Comparison
4.1.1 United States VS China: mRNA Vaccine Core Enzyme Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: mRNA Vaccine Core Enzyme Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: mRNA Vaccine Core Enzyme Production Comparison
4.2.1 United States VS China: mRNA Vaccine Core Enzyme Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: mRNA Vaccine Core Enzyme Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: mRNA Vaccine Core Enzyme Consumption Comparison
4.3.1 United States VS China: mRNA Vaccine Core Enzyme Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: mRNA Vaccine Core Enzyme Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based mRNA Vaccine Core Enzyme Manufacturers and Market Share, 2019-2024
4.4.1 United States Based mRNA Vaccine Core Enzyme Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers mRNA Vaccine Core Enzyme Production Value (2019-2024)
4.4.3 United States Based Manufacturers mRNA Vaccine Core Enzyme Production (2019-2024)
4.5 China Based mRNA Vaccine Core Enzyme Manufacturers and Market Share
4.5.1 China Based mRNA Vaccine Core Enzyme Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers mRNA Vaccine Core Enzyme Production Value (2019-2024)
4.5.3 China Based Manufacturers mRNA Vaccine Core Enzyme Production (2019-2024)
4.6 Rest of World Based mRNA Vaccine Core Enzyme Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based mRNA Vaccine Core Enzyme Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production (2019-2024)

5 Market Analysis by Enzyme Type
5.1 World mRNA Vaccine Core Enzyme Market Size Overview by Enzyme Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Enzyme Type
5.2.1 Capping Enzyme
5.2.2 2'-O-Methyltransferase
5.2.3 Inorganic Pyrophosphatase
5.2.4 Poly (A) Polymerase
5.2.5 Rnase Inhibitor
5.2.6 RNA Polymerase
5.2.7 Restriction Enzyme
5.2.8 Dnase I
5.2.9 Others
5.3 Market Segment by Enzyme Type
5.3.1 World mRNA Vaccine Core Enzyme Production by Enzyme Type (2019-2030)
5.3.2 World mRNA Vaccine Core Enzyme Production Value by Enzyme Type (2019-2030)
5.3.3 World mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2019-2030)

6 Market Analysis by Application
6.1 World mRNA Vaccine Core Enzyme Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Biopharmaceutical Companies
6.2.2 Academic and Research Institutions
6.3 Market Segment by Application
6.3.1 World mRNA Vaccine Core Enzyme Production by Application (2019-2030)
6.3.2 World mRNA Vaccine Core Enzyme Production Value by Application (2019-2030)
6.3.3 World mRNA Vaccine Core Enzyme Average Price by Application (2019-2030)

7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Details
7.1.2 Thermo Fisher Major Business
7.1.3 Thermo Fisher mRNA Vaccine Core Enzyme Product and Services
7.1.4 Thermo Fisher mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Thermo Fisher Recent Developments/Updates
7.1.6 Thermo Fisher Competitive Strengths & Weaknesses
7.2 NEB
7.2.1 NEB Details
7.2.2 NEB Major Business
7.2.3 NEB mRNA Vaccine Core Enzyme Product and Services
7.2.4 NEB mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 NEB Recent Developments/Updates
7.2.6 NEB Competitive Strengths & Weaknesses
7.3 TriLink Bio Technologies
7.3.1 TriLink Bio Technologies Details
7.3.2 TriLink Bio Technologies Major Business
7.3.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Product and Services
7.3.4 TriLink Bio Technologies mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 TriLink Bio Technologies Recent Developments/Updates
7.3.6 TriLink Bio Technologies Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck mRNA Vaccine Core Enzyme Product and Services
7.4.4 Merck mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 Aldevron
7.5.1 Aldevron Details
7.5.2 Aldevron Major Business
7.5.3 Aldevron mRNA Vaccine Core Enzyme Product and Services
7.5.4 Aldevron mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Aldevron Recent Developments/Updates
7.5.6 Aldevron Competitive Strengths & Weaknesses
7.6 Qiagen N.V.
7.6.1 Qiagen N.V. Details
7.6.2 Qiagen N.V. Major Business
7.6.3 Qiagen N.V. mRNA Vaccine Core Enzyme Product and Services
7.6.4 Qiagen N.V. mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Qiagen N.V. Recent Developments/Updates
7.6.6 Qiagen N.V. Competitive Strengths & Weaknesses
7.7 Promega
7.7.1 Promega Details
7.7.2 Promega Major Business
7.7.3 Promega mRNA Vaccine Core Enzyme Product and Services
7.7.4 Promega mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Promega Recent Developments/Updates
7.7.6 Promega Competitive Strengths & Weaknesses
7.8 Roche CustomBiotech
7.8.1 Roche CustomBiotech Details
7.8.2 Roche CustomBiotech Major Business
7.8.3 Roche CustomBiotech mRNA Vaccine Core Enzyme Product and Services
7.8.4 Roche CustomBiotech mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Roche CustomBiotech Recent Developments/Updates
7.8.6 Roche CustomBiotech Competitive Strengths & Weaknesses
7.9 Takara Bio Inc.
7.9.1 Takara Bio Inc. Details
7.9.2 Takara Bio Inc. Major Business
7.9.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Product and Services
7.9.4 Takara Bio Inc. mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Takara Bio Inc. Recent Developments/Updates
7.9.6 Takara Bio Inc. Competitive Strengths & Weaknesses
7.10 Novoprotein
7.10.1 Novoprotein Details
7.10.2 Novoprotein Major Business
7.10.3 Novoprotein mRNA Vaccine Core Enzyme Product and Services
7.10.4 Novoprotein mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Novoprotein Recent Developments/Updates
7.10.6 Novoprotein Competitive Strengths & Weaknesses
7.11 Vazyme
7.11.1 Vazyme Details
7.11.2 Vazyme Major Business
7.11.3 Vazyme mRNA Vaccine Core Enzyme Product and Services
7.11.4 Vazyme mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Vazyme Recent Developments/Updates
7.11.6 Vazyme Competitive Strengths & Weaknesses
7.12 Hongene Biotech Corporatio
7.12.1 Hongene Biotech Corporatio Details
7.12.2 Hongene Biotech Corporatio Major Business
7.12.3 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product and Services
7.12.4 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Hongene Biotech Corporatio Recent Developments/Updates
7.12.6 Hongene Biotech Corporatio Competitive Strengths & Weaknesses
7.13 Yeasen Biotechnology
7.13.1 Yeasen Biotechnology Details
7.13.2 Yeasen Biotechnology Major Business
7.13.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Product and Services
7.13.4 Yeasen Biotechnology mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Yeasen Biotechnology Recent Developments/Updates
7.13.6 Yeasen Biotechnology Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 mRNA Vaccine Core Enzyme Industry Chain
8.2 mRNA Vaccine Core Enzyme Upstream Analysis
8.2.1 mRNA Vaccine Core Enzyme Core Raw Materials
8.2.2 Main Manufacturers of mRNA Vaccine Core Enzyme Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 mRNA Vaccine Core Enzyme Production Mode
8.6 mRNA Vaccine Core Enzyme Procurement Model
8.7 mRNA Vaccine Core Enzyme Industry Sales Model and Sales Channels
8.7.1 mRNA Vaccine Core Enzyme Sales Model
8.7.2 mRNA Vaccine Core Enzyme Typical Distributors

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World mRNA Vaccine Core Enzyme Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World mRNA Vaccine Core Enzyme Production Value by Region (2019-2024) & (USD Million)
Table 3. World mRNA Vaccine Core Enzyme Production Value by Region (2025-2030) & (USD Million)
Table 4. World mRNA Vaccine Core Enzyme Production Value Market Share by Region (2019-2024)
Table 5. World mRNA Vaccine Core Enzyme Production Value Market Share by Region (2025-2030)
Table 6. World mRNA Vaccine Core Enzyme Production by Region (2019-2024) & (K Units)
Table 7. World mRNA Vaccine Core Enzyme Production by Region (2025-2030) & (K Units)
Table 8. World mRNA Vaccine Core Enzyme Production Market Share by Region (2019-2024)
Table 9. World mRNA Vaccine Core Enzyme Production Market Share by Region (2025-2030)
Table 10. World mRNA Vaccine Core Enzyme Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World mRNA Vaccine Core Enzyme Average Price by Region (2025-2030) & (US$/Unit)
Table 12. mRNA Vaccine Core Enzyme Major Market Trends
Table 13. World mRNA Vaccine Core Enzyme Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World mRNA Vaccine Core Enzyme Consumption by Region (2019-2024) & (K Units)
Table 15. World mRNA Vaccine Core Enzyme Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World mRNA Vaccine Core Enzyme Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key mRNA Vaccine Core Enzyme Producers in 2023
Table 18. World mRNA Vaccine Core Enzyme Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key mRNA Vaccine Core Enzyme Producers in 2023
Table 20. World mRNA Vaccine Core Enzyme Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global mRNA Vaccine Core Enzyme Company Evaluation Quadrant
Table 22. World mRNA Vaccine Core Enzyme Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and mRNA Vaccine Core Enzyme Production Site of Key Manufacturer
Table 24. mRNA Vaccine Core Enzyme Market: Company Product Type Footprint
Table 25. mRNA Vaccine Core Enzyme Market: Company Product Application Footprint
Table 26. mRNA Vaccine Core Enzyme Competitive Factors
Table 27. mRNA Vaccine Core Enzyme New Entrant and Capacity Expansion Plans
Table 28. mRNA Vaccine Core Enzyme Mergers & Acquisitions Activity
Table 29. United States VS China mRNA Vaccine Core Enzyme Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China mRNA Vaccine Core Enzyme Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China mRNA Vaccine Core Enzyme Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based mRNA Vaccine Core Enzyme Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers mRNA Vaccine Core Enzyme Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers mRNA Vaccine Core Enzyme Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers mRNA Vaccine Core Enzyme Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers mRNA Vaccine Core Enzyme Production Market Share (2019-2024)
Table 37. China Based mRNA Vaccine Core Enzyme Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers mRNA Vaccine Core Enzyme Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers mRNA Vaccine Core Enzyme Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers mRNA Vaccine Core Enzyme Production, (2019-2024) & (K Units)
Table 41. China Based Manufacturers mRNA Vaccine Core Enzyme Production Market Share (2019-2024)
Table 42. Rest of World Based mRNA Vaccine Core Enzyme Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production, (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production Market Share (2019-2024)
Table 47. World mRNA Vaccine Core Enzyme Production Value by Enzyme Type, (USD Million), 2019 & 2023 & 2030
Table 48. World mRNA Vaccine Core Enzyme Production by Enzyme Type (2019-2024) & (K Units)
Table 49. World mRNA Vaccine Core Enzyme Production by Enzyme Type (2025-2030) & (K Units)
Table 50. World mRNA Vaccine Core Enzyme Production Value by Enzyme Type (2019-2024) & (USD Million)
Table 51. World mRNA Vaccine Core Enzyme Production Value by Enzyme Type (2025-2030) & (USD Million)
Table 52. World mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2019-2024) & (US$/Unit)
Table 53. World mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2025-2030) & (US$/Unit)
Table 54. World mRNA Vaccine Core Enzyme Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World mRNA Vaccine Core Enzyme Production by Application (2019-2024) & (K Units)
Table 56. World mRNA Vaccine Core Enzyme Production by Application (2025-2030) & (K Units)
Table 57. World mRNA Vaccine Core Enzyme Production Value by Application (2019-2024) & (USD Million)
Table 58. World mRNA Vaccine Core Enzyme Production Value by Application (2025-2030) & (USD Million)
Table 59. World mRNA Vaccine Core Enzyme Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World mRNA Vaccine Core Enzyme Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 62. Thermo Fisher Major Business
Table 63. Thermo Fisher mRNA Vaccine Core Enzyme Product and Services
Table 64. Thermo Fisher mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Thermo Fisher Recent Developments/Updates
Table 66. Thermo Fisher Competitive Strengths & Weaknesses
Table 67. NEB Basic Information, Manufacturing Base and Competitors
Table 68. NEB Major Business
Table 69. NEB mRNA Vaccine Core Enzyme Product and Services
Table 70. NEB mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. NEB Recent Developments/Updates
Table 72. NEB Competitive Strengths & Weaknesses
Table 73. TriLink Bio Technologies Basic Information, Manufacturing Base and Competitors
Table 74. TriLink Bio Technologies Major Business
Table 75. TriLink Bio Technologies mRNA Vaccine Core Enzyme Product and Services
Table 76. TriLink Bio Technologies mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. TriLink Bio Technologies Recent Developments/Updates
Table 78. TriLink Bio Technologies Competitive Strengths & Weaknesses
Table 79. Merck Basic Information, Manufacturing Base and Competitors
Table 80. Merck Major Business
Table 81. Merck mRNA Vaccine Core Enzyme Product and Services
Table 82. Merck mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Merck Recent Developments/Updates
Table 84. Merck Competitive Strengths & Weaknesses
Table 85. Aldevron Basic Information, Manufacturing Base and Competitors
Table 86. Aldevron Major Business
Table 87. Aldevron mRNA Vaccine Core Enzyme Product and Services
Table 88. Aldevron mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Aldevron Recent Developments/Updates
Table 90. Aldevron Competitive Strengths & Weaknesses
Table 91. Qiagen N.V. Basic Information, Manufacturing Base and Competitors
Table 92. Qiagen N.V. Major Business
Table 93. Qiagen N.V. mRNA Vaccine Core Enzyme Product and Services
Table 94. Qiagen N.V. mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Qiagen N.V. Recent Developments/Updates
Table 96. Qiagen N.V. Competitive Strengths & Weaknesses
Table 97. Promega Basic Information, Manufacturing Base and Competitors
Table 98. Promega Major Business
Table 99. Promega mRNA Vaccine Core Enzyme Product and Services
Table 100. Promega mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Promega Recent Developments/Updates
Table 102. Promega Competitive Strengths & Weaknesses
Table 103. Roche CustomBiotech Basic Information, Manufacturing Base and Competitors
Table 104. Roche CustomBiotech Major Business
Table 105. Roche CustomBiotech mRNA Vaccine Core Enzyme Product and Services
Table 106. Roche CustomBiotech mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Roche CustomBiotech Recent Developments/Updates
Table 108. Roche CustomBiotech Competitive Strengths & Weaknesses
Table 109. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Takara Bio Inc. Major Business
Table 111. Takara Bio Inc. mRNA Vaccine Core Enzyme Product and Services
Table 112. Takara Bio Inc. mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Takara Bio Inc. Recent Developments/Updates
Table 114. Takara Bio Inc. Competitive Strengths & Weaknesses
Table 115. Novoprotein Basic Information, Manufacturing Base and Competitors
Table 116. Novoprotein Major Business
Table 117. Novoprotein mRNA Vaccine Core Enzyme Product and Services
Table 118. Novoprotein mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Novoprotein Recent Developments/Updates
Table 120. Novoprotein Competitive Strengths & Weaknesses
Table 121. Vazyme Basic Information, Manufacturing Base and Competitors
Table 122. Vazyme Major Business
Table 123. Vazyme mRNA Vaccine Core Enzyme Product and Services
Table 124. Vazyme mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Vazyme Recent Developments/Updates
Table 126. Vazyme Competitive Strengths & Weaknesses
Table 127. Hongene Biotech Corporatio Basic Information, Manufacturing Base and Competitors
Table 128. Hongene Biotech Corporatio Major Business
Table 129. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product and Services
Table 130. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Hongene Biotech Corporatio Recent Developments/Updates
Table 132. Hongene Biotech Corporatio Competitive Strengths & Weaknesses
Table 133. Yeasen Biotechnology Basic Information, Manufacturing Base and Competitors
Table 134. Yeasen Biotechnology Major Business
Table 135. Yeasen Biotechnology mRNA Vaccine Core Enzyme Product and Services
Table 136. Yeasen Biotechnology mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Yeasen Biotechnology Recent Developments/Updates
Table 138. Yeasen Biotechnology Competitive Strengths & Weaknesses
Table 139. Global Key Players of mRNA Vaccine Core Enzyme Upstream (Raw Materials)
Table 140. Global mRNA Vaccine Core Enzyme Typical Customers
Table 141. mRNA Vaccine Core Enzyme Typical Distributors


List of Figures
Figure 1. mRNA Vaccine Core Enzyme Picture
Figure 2. World mRNA Vaccine Core Enzyme Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World mRNA Vaccine Core Enzyme Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World mRNA Vaccine Core Enzyme Production (2019-2030) & (K Units)
Figure 5. World mRNA Vaccine Core Enzyme Average Price (2019-2030) & (US$/Unit)
Figure 6. World mRNA Vaccine Core Enzyme Production Value Market Share by Region (2019-2030)
Figure 7. World mRNA Vaccine Core Enzyme Production Market Share by Region (2019-2030)
Figure 8. North America mRNA Vaccine Core Enzyme Production (2019-2030) & (K Units)
Figure 9. Europe mRNA Vaccine Core Enzyme Production (2019-2030) & (K Units)
Figure 10. China mRNA Vaccine Core Enzyme Production (2019-2030) & (K Units)
Figure 11. Latin America mRNA Vaccine Core Enzyme Production (2019-2030) & (K Units)
Figure 12. Middle East & Africa mRNA Vaccine Core Enzyme Production (2019-2030) & (K Units)
Figure 13. mRNA Vaccine Core Enzyme Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 16. World mRNA Vaccine Core Enzyme Consumption Market Share by Region (2019-2030)
Figure 17. United States mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 18. China mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 19. Europe mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 20. Japan mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 21. South Korea mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 22. ASEAN mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 23. India mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 24. Producer Shipments of mRNA Vaccine Core Enzyme by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for mRNA Vaccine Core Enzyme Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for mRNA Vaccine Core Enzyme Markets in 2023
Figure 27. United States VS China: mRNA Vaccine Core Enzyme Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: mRNA Vaccine Core Enzyme Production Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: mRNA Vaccine Core Enzyme Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States Based Manufacturers mRNA Vaccine Core Enzyme Production Market Share 2023
Figure 31. China Based Manufacturers mRNA Vaccine Core Enzyme Production Market Share 2023
Figure 32. Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production Market Share 2023
Figure 33. World mRNA Vaccine Core Enzyme Production Value by Enzyme Type, (USD Million), 2019 & 2023 & 2030
Figure 34. World mRNA Vaccine Core Enzyme Production Value Market Share by Enzyme Type in 2023
Figure 35. Capping Enzyme
Figure 36. 2'-O-Methyltransferase
Figure 37. Inorganic Pyrophosphatase
Figure 38. Poly (A) Polymerase
Figure 39. Rnase Inhibitor
Figure 40. RNA Polymerase
Figure 41. Restriction Enzyme
Figure 42. Dnase I
Figure 43. Restriction Enzyme
Figure 44. World mRNA Vaccine Core Enzyme Production Market Share by Enzyme Type (2019-2030)
Figure 45. World mRNA Vaccine Core Enzyme Production Value Market Share by Enzyme Type (2019-2030)
Figure 46. World mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2019-2030) & (US$/Unit)
Figure 47. World mRNA Vaccine Core Enzyme Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 48. World mRNA Vaccine Core Enzyme Production Value Market Share by Application in 2023
Figure 49. Biopharmaceutical Companies
Figure 50. Academic and Research Institutions
Figure 51. World mRNA Vaccine Core Enzyme Production Market Share by Application (2019-2030)
Figure 52. World mRNA Vaccine Core Enzyme Production Value Market Share by Application (2019-2030)
Figure 53. World mRNA Vaccine Core Enzyme Average Price by Application (2019-2030) & (US$/Unit)
Figure 54. mRNA Vaccine Core Enzyme Industry Chain
Figure 55. mRNA Vaccine Core Enzyme Procurement Model
Figure 56. mRNA Vaccine Core Enzyme Sales Model
Figure 57. mRNA Vaccine Core Enzyme Sales Channels, Direct Sales, and Distribution
Figure 58. Methodology
Figure 59. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
btl

Related Reports

Global mRNA Vaccine Core Enzyme Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 xian22

Global mRNA Vaccine Core Enzyme Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 12 Mar 2024

date Medical Care

mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global mRNA Vaccine Core Enzyme Supply, Demand and Key Producers, 2024-2030

Global mRNA Vaccine Core Enzyme Supply, Demand and Key Producers, 2024-2030

Page: 125

Published Date: 12 Mar 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.

The global mRNA Vaccine Core Enzyme market size is expected to reach $ 1782 million by 2030, rising at a market growth of -2.4% CAGR during the forecast period (2024-2030).

The core manufacturers of mRNA Vaccine Core Enzyme mainly include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, etc. The top four companies in the industry account for about 49% of the market. North America is the largest market, accounting for about 38% of the global market share. In terms of product type, Capping Enzyme have the largest market share of about 25%. From an application perspective, Biopharmaceutical Companies account for the largest share at around 84%.

This report studies the global mRNA Vaccine Core Enzyme production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for mRNA Vaccine Core Enzyme and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of mRNA Vaccine Core Enzyme that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global mRNA Vaccine Core Enzyme total production and demand, 2019-2030, (K Units)
Global mRNA Vaccine Core Enzyme total production value, 2019-2030, (USD Million)
Global mRNA Vaccine Core Enzyme production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global mRNA Vaccine Core Enzyme consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: mRNA Vaccine Core Enzyme domestic production, consumption, key domestic manufacturers and share
Global mRNA Vaccine Core Enzyme production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global mRNA Vaccine Core Enzyme production by Enzyme Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global mRNA Vaccine Core Enzyme production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global mRNA Vaccine Core Enzyme market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, Takara Bio Inc., Novoprotein, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World mRNA Vaccine Core Enzyme market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Enzyme Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global mRNA Vaccine Core Enzyme Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global mRNA Vaccine Core Enzyme Market, Segmentation by Enzyme Type:
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others

Global mRNA Vaccine Core Enzyme Market, Segmentation by Application:
Biopharmaceutical Companies
Academic and Research Institutions

Companies Profiled:
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology

Key Questions Answered:
1. How big is the global mRNA Vaccine Core Enzyme market?
2. What is the demand of the global mRNA Vaccine Core Enzyme market?
3. What is the year over year growth of the global mRNA Vaccine Core Enzyme market?
4. What is the production and production value of the global mRNA Vaccine Core Enzyme market?
5. Who are the key producers in the global mRNA Vaccine Core Enzyme market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 mRNA Vaccine Core Enzyme Introduction
1.2 World mRNA Vaccine Core Enzyme Supply & Forecast
1.2.1 World mRNA Vaccine Core Enzyme Production Value (2019 & 2023 & 2030)
1.2.2 World mRNA Vaccine Core Enzyme Production (2019-2030)
1.2.3 World mRNA Vaccine Core Enzyme Pricing Trends (2019-2030)
1.3 World mRNA Vaccine Core Enzyme Production by Region (Based on Production Site)
1.3.1 World mRNA Vaccine Core Enzyme Production Value by Region (2019-2030)
1.3.2 World mRNA Vaccine Core Enzyme Production by Region (2019-2030)
1.3.3 World mRNA Vaccine Core Enzyme Average Price by Region (2019-2030)
1.3.4 North America mRNA Vaccine Core Enzyme Production (2019-2030)
1.3.5 Europe mRNA Vaccine Core Enzyme Production (2019-2030)
1.3.6 China mRNA Vaccine Core Enzyme Production (2019-2030)
1.3.7 Latin America mRNA Vaccine Core Enzyme Production (2019-2030)
1.3.8 Middle East & Africa mRNA Vaccine Core Enzyme Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 mRNA Vaccine Core Enzyme Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 mRNA Vaccine Core Enzyme Major Market Trends

2 Demand Summary
2.1 World mRNA Vaccine Core Enzyme Demand (2019-2030)
2.2 World mRNA Vaccine Core Enzyme Consumption by Region
2.2.1 World mRNA Vaccine Core Enzyme Consumption by Region (2019-2024)
2.2.2 World mRNA Vaccine Core Enzyme Consumption Forecast by Region (2025-2030)
2.3 United States mRNA Vaccine Core Enzyme Consumption (2019-2030)
2.4 China mRNA Vaccine Core Enzyme Consumption (2019-2030)
2.5 Europe mRNA Vaccine Core Enzyme Consumption (2019-2030)
2.6 Japan mRNA Vaccine Core Enzyme Consumption (2019-2030)
2.7 South Korea mRNA Vaccine Core Enzyme Consumption (2019-2030)
2.8 ASEAN mRNA Vaccine Core Enzyme Consumption (2019-2030)
2.9 India mRNA Vaccine Core Enzyme Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
3.1 World mRNA Vaccine Core Enzyme Production Value by Manufacturer (2019-2024)
3.2 World mRNA Vaccine Core Enzyme Production by Manufacturer (2019-2024)
3.3 World mRNA Vaccine Core Enzyme Average Price by Manufacturer (2019-2024)
3.4 mRNA Vaccine Core Enzyme Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global mRNA Vaccine Core Enzyme Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for mRNA Vaccine Core Enzyme in 2023
3.5.3 Global Concentration Ratios (CR8) for mRNA Vaccine Core Enzyme in 2023
3.6 mRNA Vaccine Core Enzyme Market: Overall Company Footprint Analysis
3.6.1 mRNA Vaccine Core Enzyme Market: Region Footprint
3.6.2 mRNA Vaccine Core Enzyme Market: Company Product Type Footprint
3.6.3 mRNA Vaccine Core Enzyme Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: mRNA Vaccine Core Enzyme Production Value Comparison
4.1.1 United States VS China: mRNA Vaccine Core Enzyme Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: mRNA Vaccine Core Enzyme Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: mRNA Vaccine Core Enzyme Production Comparison
4.2.1 United States VS China: mRNA Vaccine Core Enzyme Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: mRNA Vaccine Core Enzyme Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: mRNA Vaccine Core Enzyme Consumption Comparison
4.3.1 United States VS China: mRNA Vaccine Core Enzyme Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: mRNA Vaccine Core Enzyme Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based mRNA Vaccine Core Enzyme Manufacturers and Market Share, 2019-2024
4.4.1 United States Based mRNA Vaccine Core Enzyme Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers mRNA Vaccine Core Enzyme Production Value (2019-2024)
4.4.3 United States Based Manufacturers mRNA Vaccine Core Enzyme Production (2019-2024)
4.5 China Based mRNA Vaccine Core Enzyme Manufacturers and Market Share
4.5.1 China Based mRNA Vaccine Core Enzyme Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers mRNA Vaccine Core Enzyme Production Value (2019-2024)
4.5.3 China Based Manufacturers mRNA Vaccine Core Enzyme Production (2019-2024)
4.6 Rest of World Based mRNA Vaccine Core Enzyme Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based mRNA Vaccine Core Enzyme Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production (2019-2024)

5 Market Analysis by Enzyme Type
5.1 World mRNA Vaccine Core Enzyme Market Size Overview by Enzyme Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Enzyme Type
5.2.1 Capping Enzyme
5.2.2 2'-O-Methyltransferase
5.2.3 Inorganic Pyrophosphatase
5.2.4 Poly (A) Polymerase
5.2.5 Rnase Inhibitor
5.2.6 RNA Polymerase
5.2.7 Restriction Enzyme
5.2.8 Dnase I
5.2.9 Others
5.3 Market Segment by Enzyme Type
5.3.1 World mRNA Vaccine Core Enzyme Production by Enzyme Type (2019-2030)
5.3.2 World mRNA Vaccine Core Enzyme Production Value by Enzyme Type (2019-2030)
5.3.3 World mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2019-2030)

6 Market Analysis by Application
6.1 World mRNA Vaccine Core Enzyme Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Biopharmaceutical Companies
6.2.2 Academic and Research Institutions
6.3 Market Segment by Application
6.3.1 World mRNA Vaccine Core Enzyme Production by Application (2019-2030)
6.3.2 World mRNA Vaccine Core Enzyme Production Value by Application (2019-2030)
6.3.3 World mRNA Vaccine Core Enzyme Average Price by Application (2019-2030)

7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Details
7.1.2 Thermo Fisher Major Business
7.1.3 Thermo Fisher mRNA Vaccine Core Enzyme Product and Services
7.1.4 Thermo Fisher mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Thermo Fisher Recent Developments/Updates
7.1.6 Thermo Fisher Competitive Strengths & Weaknesses
7.2 NEB
7.2.1 NEB Details
7.2.2 NEB Major Business
7.2.3 NEB mRNA Vaccine Core Enzyme Product and Services
7.2.4 NEB mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 NEB Recent Developments/Updates
7.2.6 NEB Competitive Strengths & Weaknesses
7.3 TriLink Bio Technologies
7.3.1 TriLink Bio Technologies Details
7.3.2 TriLink Bio Technologies Major Business
7.3.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Product and Services
7.3.4 TriLink Bio Technologies mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 TriLink Bio Technologies Recent Developments/Updates
7.3.6 TriLink Bio Technologies Competitive Strengths & Weaknesses
7.4 Merck
7.4.1 Merck Details
7.4.2 Merck Major Business
7.4.3 Merck mRNA Vaccine Core Enzyme Product and Services
7.4.4 Merck mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Merck Recent Developments/Updates
7.4.6 Merck Competitive Strengths & Weaknesses
7.5 Aldevron
7.5.1 Aldevron Details
7.5.2 Aldevron Major Business
7.5.3 Aldevron mRNA Vaccine Core Enzyme Product and Services
7.5.4 Aldevron mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Aldevron Recent Developments/Updates
7.5.6 Aldevron Competitive Strengths & Weaknesses
7.6 Qiagen N.V.
7.6.1 Qiagen N.V. Details
7.6.2 Qiagen N.V. Major Business
7.6.3 Qiagen N.V. mRNA Vaccine Core Enzyme Product and Services
7.6.4 Qiagen N.V. mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Qiagen N.V. Recent Developments/Updates
7.6.6 Qiagen N.V. Competitive Strengths & Weaknesses
7.7 Promega
7.7.1 Promega Details
7.7.2 Promega Major Business
7.7.3 Promega mRNA Vaccine Core Enzyme Product and Services
7.7.4 Promega mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Promega Recent Developments/Updates
7.7.6 Promega Competitive Strengths & Weaknesses
7.8 Roche CustomBiotech
7.8.1 Roche CustomBiotech Details
7.8.2 Roche CustomBiotech Major Business
7.8.3 Roche CustomBiotech mRNA Vaccine Core Enzyme Product and Services
7.8.4 Roche CustomBiotech mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Roche CustomBiotech Recent Developments/Updates
7.8.6 Roche CustomBiotech Competitive Strengths & Weaknesses
7.9 Takara Bio Inc.
7.9.1 Takara Bio Inc. Details
7.9.2 Takara Bio Inc. Major Business
7.9.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Product and Services
7.9.4 Takara Bio Inc. mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Takara Bio Inc. Recent Developments/Updates
7.9.6 Takara Bio Inc. Competitive Strengths & Weaknesses
7.10 Novoprotein
7.10.1 Novoprotein Details
7.10.2 Novoprotein Major Business
7.10.3 Novoprotein mRNA Vaccine Core Enzyme Product and Services
7.10.4 Novoprotein mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Novoprotein Recent Developments/Updates
7.10.6 Novoprotein Competitive Strengths & Weaknesses
7.11 Vazyme
7.11.1 Vazyme Details
7.11.2 Vazyme Major Business
7.11.3 Vazyme mRNA Vaccine Core Enzyme Product and Services
7.11.4 Vazyme mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Vazyme Recent Developments/Updates
7.11.6 Vazyme Competitive Strengths & Weaknesses
7.12 Hongene Biotech Corporatio
7.12.1 Hongene Biotech Corporatio Details
7.12.2 Hongene Biotech Corporatio Major Business
7.12.3 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product and Services
7.12.4 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.12.5 Hongene Biotech Corporatio Recent Developments/Updates
7.12.6 Hongene Biotech Corporatio Competitive Strengths & Weaknesses
7.13 Yeasen Biotechnology
7.13.1 Yeasen Biotechnology Details
7.13.2 Yeasen Biotechnology Major Business
7.13.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Product and Services
7.13.4 Yeasen Biotechnology mRNA Vaccine Core Enzyme Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.13.5 Yeasen Biotechnology Recent Developments/Updates
7.13.6 Yeasen Biotechnology Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 mRNA Vaccine Core Enzyme Industry Chain
8.2 mRNA Vaccine Core Enzyme Upstream Analysis
8.2.1 mRNA Vaccine Core Enzyme Core Raw Materials
8.2.2 Main Manufacturers of mRNA Vaccine Core Enzyme Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 mRNA Vaccine Core Enzyme Production Mode
8.6 mRNA Vaccine Core Enzyme Procurement Model
8.7 mRNA Vaccine Core Enzyme Industry Sales Model and Sales Channels
8.7.1 mRNA Vaccine Core Enzyme Sales Model
8.7.2 mRNA Vaccine Core Enzyme Typical Distributors

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World mRNA Vaccine Core Enzyme Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World mRNA Vaccine Core Enzyme Production Value by Region (2019-2024) & (USD Million)
Table 3. World mRNA Vaccine Core Enzyme Production Value by Region (2025-2030) & (USD Million)
Table 4. World mRNA Vaccine Core Enzyme Production Value Market Share by Region (2019-2024)
Table 5. World mRNA Vaccine Core Enzyme Production Value Market Share by Region (2025-2030)
Table 6. World mRNA Vaccine Core Enzyme Production by Region (2019-2024) & (K Units)
Table 7. World mRNA Vaccine Core Enzyme Production by Region (2025-2030) & (K Units)
Table 8. World mRNA Vaccine Core Enzyme Production Market Share by Region (2019-2024)
Table 9. World mRNA Vaccine Core Enzyme Production Market Share by Region (2025-2030)
Table 10. World mRNA Vaccine Core Enzyme Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World mRNA Vaccine Core Enzyme Average Price by Region (2025-2030) & (US$/Unit)
Table 12. mRNA Vaccine Core Enzyme Major Market Trends
Table 13. World mRNA Vaccine Core Enzyme Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World mRNA Vaccine Core Enzyme Consumption by Region (2019-2024) & (K Units)
Table 15. World mRNA Vaccine Core Enzyme Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World mRNA Vaccine Core Enzyme Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key mRNA Vaccine Core Enzyme Producers in 2023
Table 18. World mRNA Vaccine Core Enzyme Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key mRNA Vaccine Core Enzyme Producers in 2023
Table 20. World mRNA Vaccine Core Enzyme Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global mRNA Vaccine Core Enzyme Company Evaluation Quadrant
Table 22. World mRNA Vaccine Core Enzyme Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and mRNA Vaccine Core Enzyme Production Site of Key Manufacturer
Table 24. mRNA Vaccine Core Enzyme Market: Company Product Type Footprint
Table 25. mRNA Vaccine Core Enzyme Market: Company Product Application Footprint
Table 26. mRNA Vaccine Core Enzyme Competitive Factors
Table 27. mRNA Vaccine Core Enzyme New Entrant and Capacity Expansion Plans
Table 28. mRNA Vaccine Core Enzyme Mergers & Acquisitions Activity
Table 29. United States VS China mRNA Vaccine Core Enzyme Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China mRNA Vaccine Core Enzyme Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China mRNA Vaccine Core Enzyme Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based mRNA Vaccine Core Enzyme Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers mRNA Vaccine Core Enzyme Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers mRNA Vaccine Core Enzyme Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers mRNA Vaccine Core Enzyme Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers mRNA Vaccine Core Enzyme Production Market Share (2019-2024)
Table 37. China Based mRNA Vaccine Core Enzyme Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers mRNA Vaccine Core Enzyme Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers mRNA Vaccine Core Enzyme Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers mRNA Vaccine Core Enzyme Production, (2019-2024) & (K Units)
Table 41. China Based Manufacturers mRNA Vaccine Core Enzyme Production Market Share (2019-2024)
Table 42. Rest of World Based mRNA Vaccine Core Enzyme Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production, (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production Market Share (2019-2024)
Table 47. World mRNA Vaccine Core Enzyme Production Value by Enzyme Type, (USD Million), 2019 & 2023 & 2030
Table 48. World mRNA Vaccine Core Enzyme Production by Enzyme Type (2019-2024) & (K Units)
Table 49. World mRNA Vaccine Core Enzyme Production by Enzyme Type (2025-2030) & (K Units)
Table 50. World mRNA Vaccine Core Enzyme Production Value by Enzyme Type (2019-2024) & (USD Million)
Table 51. World mRNA Vaccine Core Enzyme Production Value by Enzyme Type (2025-2030) & (USD Million)
Table 52. World mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2019-2024) & (US$/Unit)
Table 53. World mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2025-2030) & (US$/Unit)
Table 54. World mRNA Vaccine Core Enzyme Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World mRNA Vaccine Core Enzyme Production by Application (2019-2024) & (K Units)
Table 56. World mRNA Vaccine Core Enzyme Production by Application (2025-2030) & (K Units)
Table 57. World mRNA Vaccine Core Enzyme Production Value by Application (2019-2024) & (USD Million)
Table 58. World mRNA Vaccine Core Enzyme Production Value by Application (2025-2030) & (USD Million)
Table 59. World mRNA Vaccine Core Enzyme Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World mRNA Vaccine Core Enzyme Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 62. Thermo Fisher Major Business
Table 63. Thermo Fisher mRNA Vaccine Core Enzyme Product and Services
Table 64. Thermo Fisher mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Thermo Fisher Recent Developments/Updates
Table 66. Thermo Fisher Competitive Strengths & Weaknesses
Table 67. NEB Basic Information, Manufacturing Base and Competitors
Table 68. NEB Major Business
Table 69. NEB mRNA Vaccine Core Enzyme Product and Services
Table 70. NEB mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. NEB Recent Developments/Updates
Table 72. NEB Competitive Strengths & Weaknesses
Table 73. TriLink Bio Technologies Basic Information, Manufacturing Base and Competitors
Table 74. TriLink Bio Technologies Major Business
Table 75. TriLink Bio Technologies mRNA Vaccine Core Enzyme Product and Services
Table 76. TriLink Bio Technologies mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. TriLink Bio Technologies Recent Developments/Updates
Table 78. TriLink Bio Technologies Competitive Strengths & Weaknesses
Table 79. Merck Basic Information, Manufacturing Base and Competitors
Table 80. Merck Major Business
Table 81. Merck mRNA Vaccine Core Enzyme Product and Services
Table 82. Merck mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Merck Recent Developments/Updates
Table 84. Merck Competitive Strengths & Weaknesses
Table 85. Aldevron Basic Information, Manufacturing Base and Competitors
Table 86. Aldevron Major Business
Table 87. Aldevron mRNA Vaccine Core Enzyme Product and Services
Table 88. Aldevron mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Aldevron Recent Developments/Updates
Table 90. Aldevron Competitive Strengths & Weaknesses
Table 91. Qiagen N.V. Basic Information, Manufacturing Base and Competitors
Table 92. Qiagen N.V. Major Business
Table 93. Qiagen N.V. mRNA Vaccine Core Enzyme Product and Services
Table 94. Qiagen N.V. mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Qiagen N.V. Recent Developments/Updates
Table 96. Qiagen N.V. Competitive Strengths & Weaknesses
Table 97. Promega Basic Information, Manufacturing Base and Competitors
Table 98. Promega Major Business
Table 99. Promega mRNA Vaccine Core Enzyme Product and Services
Table 100. Promega mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Promega Recent Developments/Updates
Table 102. Promega Competitive Strengths & Weaknesses
Table 103. Roche CustomBiotech Basic Information, Manufacturing Base and Competitors
Table 104. Roche CustomBiotech Major Business
Table 105. Roche CustomBiotech mRNA Vaccine Core Enzyme Product and Services
Table 106. Roche CustomBiotech mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Roche CustomBiotech Recent Developments/Updates
Table 108. Roche CustomBiotech Competitive Strengths & Weaknesses
Table 109. Takara Bio Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Takara Bio Inc. Major Business
Table 111. Takara Bio Inc. mRNA Vaccine Core Enzyme Product and Services
Table 112. Takara Bio Inc. mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Takara Bio Inc. Recent Developments/Updates
Table 114. Takara Bio Inc. Competitive Strengths & Weaknesses
Table 115. Novoprotein Basic Information, Manufacturing Base and Competitors
Table 116. Novoprotein Major Business
Table 117. Novoprotein mRNA Vaccine Core Enzyme Product and Services
Table 118. Novoprotein mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Novoprotein Recent Developments/Updates
Table 120. Novoprotein Competitive Strengths & Weaknesses
Table 121. Vazyme Basic Information, Manufacturing Base and Competitors
Table 122. Vazyme Major Business
Table 123. Vazyme mRNA Vaccine Core Enzyme Product and Services
Table 124. Vazyme mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 125. Vazyme Recent Developments/Updates
Table 126. Vazyme Competitive Strengths & Weaknesses
Table 127. Hongene Biotech Corporatio Basic Information, Manufacturing Base and Competitors
Table 128. Hongene Biotech Corporatio Major Business
Table 129. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Product and Services
Table 130. Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 131. Hongene Biotech Corporatio Recent Developments/Updates
Table 132. Hongene Biotech Corporatio Competitive Strengths & Weaknesses
Table 133. Yeasen Biotechnology Basic Information, Manufacturing Base and Competitors
Table 134. Yeasen Biotechnology Major Business
Table 135. Yeasen Biotechnology mRNA Vaccine Core Enzyme Product and Services
Table 136. Yeasen Biotechnology mRNA Vaccine Core Enzyme Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 137. Yeasen Biotechnology Recent Developments/Updates
Table 138. Yeasen Biotechnology Competitive Strengths & Weaknesses
Table 139. Global Key Players of mRNA Vaccine Core Enzyme Upstream (Raw Materials)
Table 140. Global mRNA Vaccine Core Enzyme Typical Customers
Table 141. mRNA Vaccine Core Enzyme Typical Distributors


List of Figures
Figure 1. mRNA Vaccine Core Enzyme Picture
Figure 2. World mRNA Vaccine Core Enzyme Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World mRNA Vaccine Core Enzyme Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World mRNA Vaccine Core Enzyme Production (2019-2030) & (K Units)
Figure 5. World mRNA Vaccine Core Enzyme Average Price (2019-2030) & (US$/Unit)
Figure 6. World mRNA Vaccine Core Enzyme Production Value Market Share by Region (2019-2030)
Figure 7. World mRNA Vaccine Core Enzyme Production Market Share by Region (2019-2030)
Figure 8. North America mRNA Vaccine Core Enzyme Production (2019-2030) & (K Units)
Figure 9. Europe mRNA Vaccine Core Enzyme Production (2019-2030) & (K Units)
Figure 10. China mRNA Vaccine Core Enzyme Production (2019-2030) & (K Units)
Figure 11. Latin America mRNA Vaccine Core Enzyme Production (2019-2030) & (K Units)
Figure 12. Middle East & Africa mRNA Vaccine Core Enzyme Production (2019-2030) & (K Units)
Figure 13. mRNA Vaccine Core Enzyme Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 16. World mRNA Vaccine Core Enzyme Consumption Market Share by Region (2019-2030)
Figure 17. United States mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 18. China mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 19. Europe mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 20. Japan mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 21. South Korea mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 22. ASEAN mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 23. India mRNA Vaccine Core Enzyme Consumption (2019-2030) & (K Units)
Figure 24. Producer Shipments of mRNA Vaccine Core Enzyme by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for mRNA Vaccine Core Enzyme Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for mRNA Vaccine Core Enzyme Markets in 2023
Figure 27. United States VS China: mRNA Vaccine Core Enzyme Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: mRNA Vaccine Core Enzyme Production Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: mRNA Vaccine Core Enzyme Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States Based Manufacturers mRNA Vaccine Core Enzyme Production Market Share 2023
Figure 31. China Based Manufacturers mRNA Vaccine Core Enzyme Production Market Share 2023
Figure 32. Rest of World Based Manufacturers mRNA Vaccine Core Enzyme Production Market Share 2023
Figure 33. World mRNA Vaccine Core Enzyme Production Value by Enzyme Type, (USD Million), 2019 & 2023 & 2030
Figure 34. World mRNA Vaccine Core Enzyme Production Value Market Share by Enzyme Type in 2023
Figure 35. Capping Enzyme
Figure 36. 2'-O-Methyltransferase
Figure 37. Inorganic Pyrophosphatase
Figure 38. Poly (A) Polymerase
Figure 39. Rnase Inhibitor
Figure 40. RNA Polymerase
Figure 41. Restriction Enzyme
Figure 42. Dnase I
Figure 43. Restriction Enzyme
Figure 44. World mRNA Vaccine Core Enzyme Production Market Share by Enzyme Type (2019-2030)
Figure 45. World mRNA Vaccine Core Enzyme Production Value Market Share by Enzyme Type (2019-2030)
Figure 46. World mRNA Vaccine Core Enzyme Average Price by Enzyme Type (2019-2030) & (US$/Unit)
Figure 47. World mRNA Vaccine Core Enzyme Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 48. World mRNA Vaccine Core Enzyme Production Value Market Share by Application in 2023
Figure 49. Biopharmaceutical Companies
Figure 50. Academic and Research Institutions
Figure 51. World mRNA Vaccine Core Enzyme Production Market Share by Application (2019-2030)
Figure 52. World mRNA Vaccine Core Enzyme Production Value Market Share by Application (2019-2030)
Figure 53. World mRNA Vaccine Core Enzyme Average Price by Application (2019-2030) & (US$/Unit)
Figure 54. mRNA Vaccine Core Enzyme Industry Chain
Figure 55. mRNA Vaccine Core Enzyme Procurement Model
Figure 56. mRNA Vaccine Core Enzyme Sales Model
Figure 57. mRNA Vaccine Core Enzyme Sales Channels, Direct Sales, and Distribution
Figure 58. Methodology
Figure 59. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
btl

Related Reports

Global mRNA Vaccine Core Enzyme Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030 xian22
q3

Global mRNA Vaccine Core Enzyme Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

industry 12 Mar 2024

industry Medical Care

mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development. mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs.

jiaGou

Add To Cart

gouMai

Buy Now